23 and me has the potential to develop drugs more quickly than traditional drug makers. By march of next year, it expects to have its first drug developed fully in house in clinical trials. A company called premier has launched a new initiative to help make health care better for everyone. Visit pink dash a i com slash health care for the fool story, p i n c dash a i dotcom.
This week's Cover Story for Bloomberg Businessweek:
'23andMe Wants to Use Its Customers’ Genetic Data to Beat Cancer'
Read by Bloomberg's Mark Leydorf
CEO Anne Wojcicki wants to make drugs using insights from millions of customer DNA samples, and doesn’t think that should bother anyone.
See omnystudio.com/listener for privacy information.